Market News
Stay updated with the latest market trends, earnings, and economic indicators.
J B Chemicals & Pharmaceuticals Ltd up for fifth session
J B Chemicals & Pharmaceuticals Ltd is quoting at Rs 2419.6, up 1.24% on the day as on 12:44 IST on the NSE. The stock is up 48.86% in last one year as compared to a 4.11% spurt in NIFTY and a 16.43% spurt in the Nifty Pharma.
Saraswati Commercial (India) Ltd leads gainers in 'B' group
DB (International) Stock Brokers Ltd, IOL Chemicals & Pharmaceuticals Ltd, Kaushalya Infrastructure Development Corpn Ltd and Kothari Industrial Corporation Ltd are among the other gainers in the BSE's 'B' group today, 07 July 2026.
Logistics player A1 expands industrial chemical portfolio
A 1 Ltd, a logistics and chemical supplier, has been appointed the Primary Authorised Dealer for Ishan Dyes and Chemicals Ltd's sulphur-based industrial chemicals. This strategic move significantly expands A 1 Ltd's product offerings, including vital chemicals like Sulphuric Acid and Oleum, serving diverse sectors such as fertilisers and pharmaceuticals.
IOL Chemicals reports minor fire incident at Minoxidil manufacturing unit in Punjab
Shares of IOL Chemicals and Pharmaceuticals Ltd ended at ₹129.95, down by ₹2.95, or 2.22%, on the BSE.
J B Chemicals & Pharmaceuticals Ltd soars 1.56%
J B Chemicals & Pharmaceuticals Ltd is quoting at Rs 2206.6, up 1.56% on the day as on 12:49 IST on the NSE. The stock is up 32.31% in last one year as compared to a 7.57% spurt in NIFTY and a 10.6% spurt in the Nifty Pharma index.
Modison Ltd leads gainers in 'B' group
Hitech Corporation Ltd, Bliss GVS Pharma Ltd, Biofil Chemicals & Pharmaceuticals Ltd and Indo Rama Synthetics (India) Ltd are among the other gainers in the BSE's 'B' group today, 26 May 2026.
J B Chemicals & Pharmaceuticals Ltd rises for third consecutive session
J B Chemicals & Pharmaceuticals Ltd is quoting at Rs 2243.5, up 2.32% on the day as on 12:49 IST on the NSE. The stock is up 31.82% in last one year as compared to a 4.24% spurt in NIFTY and a 14.46% spurt in the Nifty Pharma index.
JB Chemicals Q4 net profit falls 30% to ₹101 crore as revenue declines 5%
JB Chemicals and Pharmaceuticals Q4 net profit fell 30.4 percent to 101.4 crore, revenue and EBITDA also declined, but shares rose 2.93 percent to 2215 on the BSE
J B Chemicals & Pharmaceuticals Ltd spurts 0.08%, gains for fifth straight session
J B Chemicals & Pharmaceuticals Ltd is quoting at Rs 2144.9, up 0.08% on the day as on 12:44 IST on the NSE. The stock is up 40.69% in last one year as compared to a 0.65% jump in NIFTY and a 14.52% jump in the Nifty Pharma.
J B Chemicals & Pharmaceuticals Ltd up for third straight session
J B Chemicals & Pharmaceuticals Ltd is quoting at Rs 2141, up 2.22% on the day as on 12:49 IST on the NSE. The stock is up 39.32% in last one year as compared to a 1.62% jump in NIFTY and a 12.19% jump in the Nifty Pharma index.
Stock Alert: Wockhardt, Jindal Stainless, Petronet LNG, Manappuram Finance, Aarti Industries
Larsen & Toubro, Mahindra and Mahindra, Punjab National Bank, Marico, Hero Motocorp, Lloyds Metals and Energy, SRF, Coforge, United Breweries, Poonawalla Fincorp, Ajanta Pharma, Emcure Pharmaceuticals, Aadhar Housing Finance, Gallantt Ispat, Jammu and Kashmir Bank, Voltamp Transformers, AAVAS Financiers, Lloyds Engineering Works, Alkyl Amines Chemicals, SJS Enterprises, Shilchar Technologies, GNG Electronics, Gujarat Heavy Chemicals, Aeroflex Industries, Shanthi Gears, Shoppers Stop, Dalmia Bharat Sugar and Industries, Cigniti Technologies, Raymond Realty, Raymond, Shipping Corporation of India Land and Assets, PTC India Financial Services, Spandana Sphoorty Financial, Dolphin Offshore Enterprises (India), CFF Fluid Control, DCW, Automobile Corporation of Goa (ACGL), Paushak, Mafatlal Industries, B Right Realestate, Kothari Petrochem, Foseco Crucible (India), Sutlej Textiles and Industries, Primo Chemicals, Onward Technologies, Kriti Nutrients, Jenburkt Pharma, Kriti Industries ..
Avoid chasing metal rally; focus on domestic sectors: Jyotivardhan Jaipuria
Jyotivardhan Jaipuria, Founder & MD of Valentis Advisors, says market corrections during geopolitical conflicts historically present buying opportunities, though investors should stagger investments due to oil and gas risks. He remains positive on banks, select capital goods and pharmaceuticals, while continuing to hold metals but avoiding fresh buying at current levels. Export-oriented sectors like chemicals may face near-term pressure from higher logistics and raw material costs.